-
-
-
-
-
-
-
Assertio Therapeutics (ASRT) to Acquire Spectrum Pharmaceuticals (SPPI) in Stock and CVR Deal
-
-
-
-
-
-
-
Spectrum Pharmaceuticals Provides Update on ROLVEDON™ (eflapegrastim-xnst) Injection and Announces Unaudited Fourth Quarter 2022 Financial Results
-
-
-
-
-
-
-
Spectrum Pharma (SPPI) Receives CRL for Poziotonin; Will Focus on Rolvedon
-
-
-
-
-
-
-
Spectrum Pharma (SPPI) says FDA committee voted 9-4 that current benefits of poziotinib did not outweigh its risks
-
-
-
-
-
-
-
Spectrum Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update
-
-
-
-
-
-
-
Spectrum Pharma (SPPI) Appoints Brittany K. Bradrick to its Board
-
-
-
-
-
-
-
Spectrum Pharmaceuticals Appoints Juhyun Lim of Hanmi Pharmaceutical to Board of Directors
-
916,622 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All